Abstract 2133: Ending the endless acquired tyrosine kinase resistance mutations — Design of TPX-0005, a multi-target ALK/ROS1/TRK inhibitor with broad spectrum activity against wild-type and mutants including ALK G1202R, ROS1 G2032R and TRKA G595R
Year: 2016
Type: conference-abstract
Source: Cancer Research
Authors: J. Jean Cui, Evan Rogers, Dayong Zhai, Wei Deng, Zhongdong Huang, Jeffrey Whitten, Yishan Li
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2504123697